Brian Warren

High-Dose Antithrombin III in Severe Sepsis

Brian Warren, Alain Eid, Pierre Singer et al. · JAMA · 2001 · 1.4K citations

Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-Blind Clinical Trials

Kenneth D Boffard, Bruno Riou, Brian Warren et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2005 · 779 citations

High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety*

Christian J. Wiedermann, Johannes Hoffmann, Mathias Juers et al. · Critical Care Medicine · 2006 · 186 citations

Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 Study

Martín E. Stryjewski, Vivian H. Chu, William O’Riordan et al. · Antimicrobial Agents and Chemotherapy · 2006 · 163 citations · Full text

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial*

Steven M. Opal, Pierre‐François Laterre, Edward Abraham et al. · Critical Care Medicine · 2004 · 145 citations